α-Synuclein Pathology As a Target in Neurodegenerative Diseases

Overview

Journal Nat Rev Neurol

Specialty Neurology

Date 2024 Nov 28

PMID 39609631

Authors

Hyejin Park

Tae-In Kam

Valina L Dawson

Ted M Dawson

Affiliations

Soon will be listed here.

Abstract

α-Synuclein misfolds into pathological forms that lead to various neurodegenerative diseases known collectively as α-synucleinopathies. In this Review, we provide a comprehensive overview of pivotal advances in α-synuclein research. We examine structural features and physiological functions of α-synuclein and summarize current insights into key post-translational modifications, such as nitration, phosphorylation, ubiquitination, sumoylation and truncation, considering their contributions to neurodegeneration. We also highlight the existence of disease-specific α-synuclein strains and their mechanisms of pathological spread, and discuss seed amplification assays and PET tracers as emerging diagnostic tools for detecting pathological α-synuclein in clinical settings. We also discuss α-synuclein aggregation and clearance mechanisms, and review cell-autonomous and non-cell-autonomous processes that contribute to neuronal death, including the roles of adaptive and innate immunity in α-synuclein-driven neurodegeneration. Finally, we highlight promising therapeutic approaches that target pathological α-synuclein and provide insights into emerging areas of research.

Citing Articles

Imaging Alpha-synuclein with Novel 5-Imidazo[1,5-][1,2,4]triazole Radioligands for the Diagnosis of Parkinson's Disease.

Song Z, Liang S ACS Med Chem Lett. 2025; 16(2):182-183.

PMID: 39967619 PMC: 11831397. DOI: 10.1021/acsmedchemlett.4c00607.

USP14 is crucial for proteostasis regulation and α-synuclein degradation in human SH-SY5Y dopaminergic cells.

Srinivasan V, Soliymani R, Ivanova L, Eriksson O, Peitsaro N, Lalowski M Heliyon. 2025; 11(3):e42031.

PMID: 39916840 PMC: 11795799. DOI: 10.1016/j.heliyon.2025.e42031.

Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions.

Kuo G, Kumbhar R, Blair W, Dawson V, Dawson T, Mao X Mol Neurodegener. 2025; 20(1):10.

PMID: 39849529 PMC: 11756073. DOI: 10.1186/s13024-025-00797-1.

References

Goedert M, Spillantini M . Lewy body diseases and multiple system atrophy as alpha-synucleinopathies. Mol Psychiatry. 1998; 3(6):462-5. DOI: 10.1038/sj.mp.4000458. View

Baba M, Nakajo S, Tu P, Tomita T, Nakaya K, Lee V . Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol. 1998; 152(4):879-84. PMC: 1858234. View

Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H . Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett. 1998; 249(2-3):180-2. DOI: 10.1016/s0304-3940(98)00407-8. View

Hamilton R . Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 2000; 10(3):378-84. PMC: 8098522. DOI: 10.1111/j.1750-3639.2000.tb00269.x. View

Spillantini M, Schmidt M, Lee V, Trojanowski J, Jakes R, Goedert M . Alpha-synuclein in Lewy bodies. Nature. 1997; 388(6645):839-40. DOI: 10.1038/42166. View

Bi M, Du X, Jiao Q, Chen X, Jiang H . Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown. Cell Death Dis. 2021; 12(2):154. PMC: 7862491. DOI: 10.1038/s41419-021-03441-0. View

Peng C, Trojanowski J, Lee V . Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020; 16(4):199-212. PMC: 9242841. DOI: 10.1038/s41582-020-0333-7. View

Sohrabi T, Mirzaei-Behbahani B, Zadali R, Pirhaghi M, Morozova-Roche L, Meratan A . Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease. J Mol Biol. 2023; 435(12):167992. DOI: 10.1016/j.jmb.2023.167992. View

Stykel M, Ryan S . Nitrosative stress in Parkinson's disease. NPJ Parkinsons Dis. 2022; 8(1):104. PMC: 9372037. DOI: 10.1038/s41531-022-00370-3. View

10.

Maroteaux L, Campanelli J, Scheller R . Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988; 8(8):2804-15. PMC: 6569395. View

11.

Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M . Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1993; 90(23):11282-6. PMC: 47966. DOI: 10.1073/pnas.90.23.11282. View

12.

Twohig D, Nielsen H . α-synuclein in the pathophysiology of Alzheimer's disease. Mol Neurodegener. 2019; 14(1):23. PMC: 6558879. DOI: 10.1186/s13024-019-0320-x. View

13.

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

14.

Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B . Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov Disord. 2013; 28(6):811-3. DOI: 10.1002/mds.25421. View

15.

Daida K, Shimonaka S, Shiba-Fukushima K, Ogata J, Yoshino H, Okuzumi A . α-Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid-Binding Property. Mov Disord. 2022; 37(10):2075-2085. PMC: 9796804. DOI: 10.1002/mds.29162. View

16.

Hoffman-Zacharska D, Koziorowski D, Ross O, Milewski M, Poznanski J, Jurek M . Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease. Parkinsonism Relat Disord. 2013; 19(11):1057-1060. PMC: 4055791. DOI: 10.1016/j.parkreldis.2013.07.011. View

17.

Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S . Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998; 18(2):106-8. DOI: 10.1038/ng0298-106. View

18.

Lesage S, Anheim M, Letournel F, Bousset L, Honore A, Rozas N . G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol. 2013; 73(4):459-71. DOI: 10.1002/ana.23894. View

19.

Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J . Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiol Aging. 2014; 35(9):2180.e1-5. DOI: 10.1016/j.neurobiolaging.2014.03.024. View

20.

Yoshino H, Hirano M, Stoessl A, Imamichi Y, Ikeda A, Li Y . Homozygous alpha-synuclein p.A53V in familial Parkinson's disease. Neurobiol Aging. 2017; 57:248.e7-248.e12. DOI: 10.1016/j.neurobiolaging.2017.05.022. View